Medical Device Network
The leading site for news and procurement in the medical device industry
- Website
- medicaldevice-network.com · all feeds from this site
- Feed URL
https://www.medicaldevice-network.com/feed/
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
Dexcom lifts 2026 revenue outlook after positive Q3
Dexcom now expects 2026 revenues to land in the $5.2bn to $5.25bn range, up from $5.18bn at the low-end as previously outlined. The post Dexcom lifts 2026 revenue outlook after positive Q3 appeared first on Medical Device Network .
-
Omron Healthcare begins production at first India plant
Omron Healthcare has commenced full-scale blood pressure monitor production at its first Indian manufacturing facility, situated near Chennai. The post Omron Healthcare begins production at first India plant appeared first on Medical Device Network .
-
J&J data show lower mortality with Impella in HRPCI than CHIP-BCIS3
J&J presented three clinical analyses at TCT 2026 showing lower mortality with Impella heart pump support in HRPCI patients. The post J&J data show lower mortality with Impella in HRPCI than CHIP-BCIS3 appeared first on Medical Device Network .
-
Abbott’s paravalvular leak treatment secures FDA approval
Abbott’s Amplatzer Paraclose Occluder is designed to mitigate the need for revision surgery in cases where gaps form around a replacement heart valve. The post Abbott’s paravalvular leak treatment secures FDA approval appeared first on Medical Device Network .
-
Baxter’s shares fall as Q3 probability dips despite revenue growth
Baxter’s shares fell by over 4% on 29 October after adjusted earnings per share (EPS) dipped 16% year-over-year, despite positive revenue results. The post Baxter’s shares fall as Q3 probability dips despite revenue growth appeared first on Medical Device Network .
-
FDA expands approval of Instylla’s Embrace HES for arterial bleeds
The US FDA has cleared an expanded indication for Instylla’s Embrace HES to treat peripheral arterial bleeds in vessels measuring up to 6mm. The post FDA expands approval of Instylla’s Embrace HES for arterial bleeds appeared first on Medical Device Network .
-
StimCardio secures $30m in Series A round for wearable AF therapy
StimCardio Medical has completed an oversubscribed $30m Series A funding round to advance its non-invasive wearable, Rhyvive, for AF. The post StimCardio secures $30m in Series A round for wearable AF therapy appeared first on Medical Device Network .
-
BMA laments low NHS investment in UK’s Autumn Budget
While a total of £290m was pledged to address winter pressures in the NHS and advance medical robotics, the BMA noted that NHS outlay was lower than in recent years. The post BMA laments low NHS investment in UK’s Autumn Budget appeared first on Medical Device Network .
-
Podcast: Boston Scientific on the growing importance of clinical evidence in cardiology
Boston has a growing body of evidence across AF and stroke prevention with studies, including CHAMPION-AF, BEAT AF, OPTION, and AVANT GUARD. The post Podcast: Boston Scientific on the growing importance of clinical evidence in cardiology appeared first on Medical Device Network .
-
GE HealthCare raises 2026 outlook after positive Q3
In Q3, GE HealthCare reported notable growth in PDx, a segment it moved to strengthen earlier this month with the $945m acquisition of SOFIE Biosciences. The post GE HealthCare raises 2026 outlook after positive Q3 appeared first on Medical Device Network .
-
SetPoint treats first patient with neuroimmune modulation system
SetPoint Medical has treated the first patient with its neuroimmune modulation therapy, the SetPoint system, at Boston's BIDMC. The post SetPoint treats first patient with neuroimmune modulation system appeared first on Medical Device Network .
-
Empatica introduces WellPD Parkinson’s wearable device
Empatica has launched WellPD, a FDA-cleared and CE-marked wearable system developed to monitor Parkinson's disease symptoms in home environments. The post Empatica introduces WellPD Parkinson’s wearable device appeared first on Medical Device Network .
-
Pharaoh’s CSF management system secures FDA breakthrough designation
Pharaoh’s Neurapheresis is under development to advance existing treatment options to patients following aneurysmal subarachnoid haemorrhage (aSAH). The post Pharaoh’s CSF management system secures FDA breakthrough designation appeared first on Medical Device Network .